CPIX - CIK 0001087294
CUMBERLAND PHARMACEUTICALS INC (CPIX) reported net income of -$2.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$2.84M | +56.2% |
| FY 2024 | -$6.48M | -3.2% |
| FY 2023 | -$6.28M | -12.7% |
| FY 2022 | -$5.57M | -58.8% |
| FY 2021 | -$3.51M | -5.0% |
| FY 2020 | -$3.34M | +5.6% |
| FY 2019 | -$3.54M | +49.2% |
| FY 2018 | -$6.96M | +12.7% |
| FY 2017 | -$7.98M |
CUMBERLAND PHARMACEUTICALS INC (CPIX) reported net income of -$2.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CUMBERLAND PHARMACEUTICALS INC's net income declined from $5.66M to -$2.84M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -744.6% |
| FY 2016 | -$944.68K | -229.2% |
| FY 2015 | $731.35K | -69.8% |
| FY 2014 | $2.42M | +215.2% |
| FY 2013 | -$2.10M | -136.0% |
| FY 2012 | $5.84M | +3.3% |
| FY 2011 | $5.66M | - |